Orbis Medicines raised €90M in a Series A round in Jan 2025. The company is based in Copenhagen, Denmark. Investors in the round: Cormorant, Eli Lilly, Forbion and 3 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €90M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
